Evidence map›Paper›PMID 22156202›Full record

ArticleThe Journal of clinical investigation2012

Defective nuclear IKKα function in patients with ectodermal dysplasia with immune deficiency.

Stephane T Temmerman, Chi A Ma, Yongge Zhao, Jeffrey Keenan, Ivona Aksentijevich, Margaret Fessler, Margaret R Brown, Alan Knutsen, Ralph Shapiro, Ashish Jain

Abstract readCase Reports
In one paragraph

Article in The Journal of clinical investigation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. NF-κB Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria.Mediterranean journal of hematology and infectious diseases · 2015
    Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Stephane T TemmermanLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland 20892, USA.
Chi A Ma
Yongge Zhao
Jeffrey Keenan
Ivona Aksentijevich
Margaret Fessler
Margaret R Brown
Alan Knutsen
Ralph Shapiro
Ashish Jain
National Institute of Allergy and Infectious Diseases · USNational Institute of Arthritis and Musculoskeletal and Skin Diseases · USNational Institutes of Health Clinical Center · US

Funding

The Genetics, Pathogenesis, and Treatment of Primary ImmunodeficiencyZIAAI000924 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI JAIN, ASHISH · 2009 to 2013
$4.8M
6 · The paper itself

Abstract

Ectodermal dysplasia with immune deficiency (EDI) is an immunological and developmental disorder caused by alterations in the gene encoding NF-κB essential modulator (NEMO; also known as IκB kinase γ subunit [IKKγ]). Missense mutations in the gene encoding NEMO are associated with reduced signal-induced nuclear translocation of NF-κB proteins, resulting in defective expression of NF-κB target genes. Here, we report 2 unrelated male patients with EDI, both of whom have normal NEMO coding sequences, but exhibit a marked reduction in expression of full-length NEMO protein. TLR4 stimulation of APCs from these patients induced normal cytoplasmic activation and nuclear translocation of NF-κB. However, cells deficient in full-length NEMO were defective in expression of NF-κB-regulated cytokines, such as IL-12, suggesting a downstream defect in chromatin accessibility for NF-κB transcription factors. TLR4-stimulated APCs from the patients were defective in IKKα-dependent H3 histone phosphorylation at the IL-12 promoter and recruitment of NF-κB heterodimers RelA and cRel to the promoter. Expression of a super-active form of IKKα restored IL-12 production in a NEMO knockdown human monocytic cell line following LPS treatment. Our findings suggest that NEMO regulates the nuclear function of IKKα and offer new insights into the mechanisms underlying diminished NF-κB signaling in patients with EDI.

Indexed as

AdolescentCell LineCell NucleusChild, PreschoolCytokinesDNA-Binding ProteinsEctodermal DysplasiaGene ExpressionGene Knockdown TechniquesGene RearrangementGenetic Diseases, X-LinkedHumansI-kappa B KinaseImmunologic Deficiency SyndromesInterleukin-12MaleCytokinesDNA-Binding ProteinsI-kappa B KinaseIKBKG protein, humanInterleukin-12NF-kappa BNuclear ProteinsProto-Oncogene Proteins c-relRELA protein, humanREL protein, humanTLR4 protein, humanToll-Like Receptor 4Transcription Factor RelA

Identifiers

PMID22156202
PMCPMC3248277
OpenAlexW2082476329

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.